Literature DB >> 7705929

Human T-cell lymphotropic virus type I and severe neoplasia of the cervix in Jamaica.

H D Strickler1, C Rattray, C Escoffery, A Manns, M H Schiffman, C Brown, B Cranston, B Hanchard, J M Palefsky, W A Blattner.   

Abstract

Human T-cell lymphotropic virus type I (HTLV-I) was associated with carcinoma of the cervix in Japan in a recent study that compared hospital cases with healthy population-based controls. To test this relationship in women more alike for cervical neoplasia risk factors (including sexual behavior and human papilloma virus; HPV), we enrolled consecutive patients from a colposcopy clinic in Kingston, Jamaica (an HTLV-I endemic area). Patients underwent Pap smear, colposcopy, biopsy and cervical swab for detection of HPV by polymerase chain reaction. Cases were defined as women with CIN-3 or invasive cancer (CIN-3/CA). Controls included all patients with either CIN-I or koilocytotic atypia, atypical squamous cells of undetermined significance or benign cervical pathology (all but one had at least inflammatory changes). Patients with CIN-2 were excluded to minimize risk of case-control misclassification. Cases were much more likely to be HTLV-I seropositive than controls. Although mean age differed significantly between cases (mean age = 39 years) and controls (mean age = 33 years), control for age did not explain the relation of CIN-3/CA with HTLV-I. Among HPV DNA positive subjects the age-adjusted association was not diminished but lost statistical significance. HTLV-I seroprevalence may be independently associated with progression to severe neoplasia of the cervix.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705929     DOI: 10.1002/ijc.2910610105

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease.

Authors:  J M Palefsky; E A Holly; M L Ralston; S P Arthur; C J Hogeboom; T M Darragh
Journal:  Genitourin Med       Date:  1997-06

Review 2.  HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases.

Authors:  E Eusebio-Ponce; E Anguita; R Paulino-Ramirez; F J Candel
Journal:  Rev Esp Quimioter       Date:  2019-10-25       Impact factor: 1.553

Review 3.  Small cells lung epidermoid carcinoma in a HTLV1-infected patient: case report and literature review.

Authors:  Flávia Esper Dahy; Renata Basic Palhares; Tatiane Assone; Jerusa Smid; João Victor Luisi de Moura; Michel E J Haziot; Rosa Maria N Marcusso; Augusto César Penalva de Oliveira; Jorge Casseb
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2021-04-26       Impact factor: 1.846

4.  Association between human papillomavirus and human T-lymphotropic virus in indigenous women from the Peruvian Amazon.

Authors:  Magaly M Blas; Isaac E Alva; Patricia J Garcia; Cesar Carcamo; Silvia M Montano; Ricardo Muñante; Joseph R Zunt
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

5.  Pathways of cell-cell transmission of HTLV-1.

Authors:  Claudine Pique; Kathryn S Jones
Journal:  Front Microbiol       Date:  2012-10-24       Impact factor: 5.640

6.  Analysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.

Authors:  Xiaotong He; Innocent O Maranga; Anthony W Oliver; Peter Gichangi; Lynne Hampson; Ian N Hampson
Journal:  Viruses       Date:  2016-09-05       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.